NEW YORK, May 14, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Moments ago, Analysts Review released new research updates concerning several important developing situations including Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI), Joy Global, Inc. (NYSE: JOY), Nuverra Environmental Solutions, Inc. (NYSE: NES), Viggle Inc. (NASDAQ: VGGL), and Jumei International Holding Limited (NYSE: JMEI). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
To access our full PDF reports on a complementary basis, please visit the links below.
--
Today's update concerns the following companies:
============
Full PDF Download Links (you may have to copy and paste the following links into your browser):
BCLI Research Report: ( http://get.analystsreview.com/pdf/?c=Brianstorm%20Cell%20Therapeutics&d=14-May-2015&s=BCLI ),
JOY Research Report: ( http://get.analystsreview.com/pdf/?c=Joy%20Global&d=14-May-2015&s=JOY ),
NES Research Report: ( http://get.analystsreview.com/pdf/?c=Nuverra%20Environmental%20Solutions&d=14-May-2015&s=NES ),
VGGL Research Report: ( http://get.analystsreview.com/pdf/?c=Viggle%20Inc.&d=14-May-2015&s=VGGL ),
JMEI Research Report: ( http://get.analystsreview.com/pdf/?c=Jumei%20International&d=14-May-2015&s=JMEI ).
============
--
Analyst Update: Earnings, Clinical Trialand Upcoming Events
U.S. stocks closed virtually flat on Wednesday, amid disappointing monthly retail sales data. The Dow Jones Industrial Average fell 0.04%, to finish at 18,060.49, the S&P 500 edged down 0.03%, to 2,098.48, while the NASDAQ Composite rose modestly by 0.11%, to end the session at 4,981.69. European stocks mostly closed lower on Wednesday, despite positive economic growth data. Germany's DAX 30 declined 1.05%, and France's CAC 40 slipped 0.26%. In contrast, London's FTSE 100 closed 0.23% higher on Wednesday, mainly reflecting upbeat unemployment data. Meanwhile, Asian markets were mixed on Wednesday, amid weaker Chinese economic data. The Shanghai Composite and Hong Kong's Hang Seng were both down on Wednesday, while Japan's Nikkei closed higher.
Brainstorm Cell Therapeutics Inc. (Brainstorm) presented the results from its phase 2a study of NurOwn® in amyotrophic lateral sclerosis (ALS) in a session at the American Academy of Neurology annual meeting, which took place in Washington D.C.
Joy Global, Inc. (Joy) announced its first quarter 2015 financial results for the period ended January 30, 2015, on May 5, 2015. The Consolidated net sales totaled $704 million, a 16% decrease versus the first quarter of last year, which aggregated at $839 million. On the earnings front, adjusted net income came in at $24.6 million or $0.25 per diluted share compared to $50 million or $0.49 per diluted share reported last year in the comparable period.
Nuverra Environmental Solutions Inc. (Nuverra) on May 11, 2015 reported its first quarter 2015 results with improvement of 90 bps in adjusted EBITDA margins. Revenue from continuing operations declined 7.0% year-over-year to $119.1 million during the quarter from $128.0 million in the first quarter of 2014, due to declines in the Rocky Mountain and Southern Divisions, partly offset by growth in the Northeast Division.
Viggle Inc. (Viggle) on May 11, 2015 reported its third quarter 2015 results with a 52% year-over-year revenue growth and 116% increase in net registered users. 3Q 2105 revenue aggregated $5.0 million compared with $3.3 million in the year-ago third quarter.
On May 8, 2015, Jumei International Holding Limited (Jumei) announced its plans to release its unaudited first quarter 2015 financial results after the close of US markets on Thursday, May 21, 2015. The management of the Company would also host a conference call on May 22, 2015 at 8:30 a.m. ET.
-
About Analysts Review
At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.
--
Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.
Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider, represented by a registered analyst has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
